Home/Pipeline/RG-lead-011

RG-lead-011

Rare Disease

PreclinicalActive

Key Facts

Indication
Rare Disease
Phase
Preclinical
Status
Active
Company

About RinuaGene Biotechnology

A clinical-stage biotech developing mRNA therapeutics and vaccines with a proprietary platform, targeting HPV-related diseases, rare conditions, and infectious diseases.

View full company profile

Other Rare Disease Drugs

DrugCompanyPhase
Rare Disease CollaborationUnnatural ProductsDiscovery/Optimization